Non-specific blood components and coagulation cascade

The non-specific blood components and coagulation cascade represent the physiological system responsible for maintaining hemostasis and preventing excessive blood loss following vascular injury (StatPearls, 2023). This system involves a complex series of proteolytic activations of zymogens, primarily serine proteases, culminating in the conversion of soluble fibrinogen into an insoluble fibrin mesh (Wikipedia, 2024). It is traditionally divided into the intrinsic, extrinsic, and common pathways, though these are highly integrated in vivo to ensure rapid response to injury (NIH, 2022). Beyond clotting, these components play significant roles in inflammation and the innate immune response by interacting with various cell types. Pharmacological intervention in this system is a cornerstone of cardiovascular medicine, utilizing anticoagulants, antiplatelets, and thrombolytics to prevent or treat thromboembolic events (PubMed, 2021). However, because this term describes a broad biological process and a collection of diverse proteins rather than a single molecular entity, it is considered a system-level classification rather than a specific therapeutic target.

Other names

Blood coagulation systemHemostatic systemCoagulation pathwayClotting cascadeHemostatic cascade

Drugs interacting with this system function by inhibiting specific serine proteases (e.g., Factor Xa or Thrombin), antagonizing Vitamin K-dependent carboxylation of clotting factors, preventing platelet activation and aggregation, or accelerating the degradation of fibrin through the activation of plasminogen.